Literature DB >> 177443

Presence of TSH receptor in thyroid neoplasms.

Y Ichikawa, E Saito, Y Abe, M Homma, T Muraki.   

Abstract

The nature of the TSH receptor in adenoma and carcinoma of the thyroid gland was studied using a radioreceptor assay technique. A membrane fraction of tissue homogenate was obtained by discontinuous sucrose gradient ultracentrifugation, and 125I-TSH, labelled by a lactoperoxidase method, was purified with a receptor adsorption method. Both the capacities and the association constants of high affinity receptors (4 x 10(9) M-1) and of low affinity receptors (0.073 x 10(9) M-1) observed in the normal thyroid were almost identical to those of the thyroid of Graves' disease and those of thyroid adenoma. Although the two papillary carcinomas examined were found to have two kinds of TSH receptors, one of the carcinomas showed decreased association constants for both high affinity and low affinity receptors.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 177443     DOI: 10.1210/jcem-42-2-395

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  20 in total

Review 1.  Hormonogenetic errors in thyroid tumor.

Authors:  F Monaco; M Andreoli
Journal:  J Endocrinol Invest       Date:  1978-10       Impact factor: 4.256

Review 2.  Controversies in the Management of Low-Risk Differentiated Thyroid Cancer.

Authors:  Megan R Haymart; Nazanene H Esfandiari; Michael T Stang; Julia Ann Sosa
Journal:  Endocr Rev       Date:  2017-08-01       Impact factor: 19.871

3.  Morphological demonstration and quantification of TSH binding sites in neoplastic and non-neoplastic thyroid tissues. An autoradiographic study using 125I-labelled thyrotropin.

Authors:  S Schröder; H W Müller-Gärtner; R Schroiff; P Schmiegelow; A Niendorf; W Böcker
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

4.  Mechanisms for increased adenylate cyclase responsiveness to TSH in neoplastic human thyroid tissue.

Authors:  O H Clark; P L Gerend; R A Nissenson
Journal:  World J Surg       Date:  1984-08       Impact factor: 3.352

5.  TSH suppression in the management of thyroid nodules and thyroid cancer.

Authors:  O H Clark
Journal:  World J Surg       Date:  1981-01       Impact factor: 3.352

6.  Follicular carcinoma of the thyroid with metastasis to the breast.

Authors:  R C Chisholm; E B Chung; W Tuckson; T Khan; J E White
Journal:  J Natl Med Assoc       Date:  1980-11       Impact factor: 1.798

7.  Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer.

Authors:  Jacqueline Jonklaas; Hala Nsouli-Maktabi; Steven J Soldin
Journal:  Thyroid       Date:  2008-09       Impact factor: 6.568

Review 8.  Biochemistry of thyroid regulation under normal and abnormal conditions.

Authors:  M A Pisarev; D L Kleiman de Pisarev
Journal:  J Endocrinol Invest       Date:  1980 Jul-Sep       Impact factor: 4.256

9.  Thyroid carcinoma in black patients.

Authors:  E L Mosley; E B Chung; N Rogers; J E Anderson; J E White
Journal:  J Natl Med Assoc       Date:  1978-12       Impact factor: 1.798

Review 10.  Management of differentiated thyroid cancer in the presence of resistance to thyroid hormone and TSH-secreting adenomas: a report of four cases and review of the literature.

Authors:  Uğur Ünlütürk; Chutintorn Sriphrapradang; Murat Faik Erdoğan; Rifat Emral; Sibel Güldiken; Samuel Refetoff; Sevim Güllü
Journal:  J Clin Endocrinol Metab       Date:  2013-04-03       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.